Mission and Strategy

PDF file download the PDF

Mission

To provide access to affordable good quality essential asthma drugs


Strategy

  1. Promote use of The Union’s 4 step standardised, essential medicines approach to asthma diagnosis & treatment, and its package of technical measures for quality asthma management in the general health services.

  2. Use purchasing and marketing strategies to lower prices of medicines so that they become affordable for the patient.

  3. Target populations with large numbers of patients already seeking care from services that are not yet able to buy asthma medicines.

  4. Increase awareness that disability and poverty caused by asthma can be reduced.

  5. Be an efficient, independent, transparent, sustainable drug supply system. 


Operating Principles

  • The ADF will be managed by The Union, and advised by a Steering Committee and Technical Review Panel;

  • ADF will be efficient, independent, transparent, accountable, responsive and sustainable;

  • ADF will use competitive processes, pooled procurement and other purchasing strategies to obtain the lowest possible prices for asthma medicines;

  • ADF will promote standardised cost-effective treatment regimens;

  • ADF will work with clients that meet qualifying criteria;

  • ADF will, with support from technical partners, evaluate the impact of providing middle and low-income countries with access to affordable good quality essential drugs.


Steering Committee (SC)

  • Prof. Jean Bousquet, France
  • Prof. Peter Burney, UK
  • Prof. Moira Chen-Yeung, Hong Kong
  • Prof. Tim Clark, UK
  • Prof. Asma El Sony, Sudan
  • Dr. Mario Raviglione, WHO Geneva
  • Prof. Oumou Sow, Guinea Conakry

Technical Review Panel (TRP)

  • Dr Jean-Michel Caudron, France
  • Dr. Salah Ottmani, WHO Geneva
  • Prof. Neil Pearce, New Zealand
  • Prof. Noureddine Zidouni, Algeria

Return to Top